June 2020
Volume 61, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2020
Assessing the Effect of Image Scaling on OCTA Vessel Density Deviation Mapping
Author Affiliations & Notes
  • Rachel E Linderman
    Cell Biology, Neurobiology & Anatomy, Medical College of Wisconsin, Milwaukee, Wisconsin, United States
  • Toco Yuen Ping Chui
    Ophthalmology, New York Eye and Ear Infirmary of Mount Sinai, New York, New York, United States
    Icahn School of Medicine, Mount Sinai, New York, New York, United States
  • Christopher S. Langlo
    Internal Medicine, St. Joseph Hospital, Milwaukee, Wisconsin, United States
  • Erin Curran
    Ophthalmology & Visual Sciences, Medical College of Wisconsin, Milwaukee, Wisconsin, United States
  • Davis Zhou
    Ophthalmology, New York Eye and Ear Infirmary of Mount Sinai, New York, New York, United States
    Icahn School of Medicine, Mount Sinai, New York, New York, United States
  • Maria Virginia Castanos Toral
    Ophthalmology, New York Eye and Ear Infirmary of Mount Sinai, New York, New York, United States
  • Judy E Kim
    Ophthalmology & Visual Sciences, Medical College of Wisconsin, Milwaukee, Wisconsin, United States
  • David V Weinberg
    Ophthalmology & Visual Sciences, Medical College of Wisconsin, Milwaukee, Wisconsin, United States
  • Richard B Rosen
    Ophthalmology, New York Eye and Ear Infirmary of Mount Sinai, New York, New York, United States
    Icahn School of Medicine, Mount Sinai, New York, New York, United States
  • Joseph Carroll
    Cell Biology, Neurobiology & Anatomy, Medical College of Wisconsin, Milwaukee, Wisconsin, United States
    Ophthalmology & Visual Sciences, Medical College of Wisconsin, Milwaukee, Wisconsin, United States
  • Footnotes
    Commercial Relationships   Rachel Linderman, Optovue (C); Toco Chui, None; Christopher Langlo, None; Erin Curran, None; Davis Zhou, None; Maria Castanos Toral, None; Judy Kim, Adverum (C), Allergan (C), Clearside (C), Eyepoint (C), Genentech (C), NotalVision (C), NotalVision (R), Novartis (C), Optos (R); David Weinberg, None; Richard Rosen, Advanced Cellular Technologies (C), Carl Zeiss Meditech (C), Clarity (C), NanoRetina (C), OD-OS (C), Opticology (I), OptoVue (C), OptoVue (P), Regeneron (C); Joseph Carroll, AGTC (F), MeiraGTx (C), MeiraGTx (F), OptoVue (F), Translational Imaging Innovations (I)
  • Footnotes
    Support  C06RR016511, P30DK020595, R01EY024969, P30EY001931, R01EY027301, UL1TR001436, The Gene and Ruth Posner Foundation, The Lowy Medical Research Institute
Investigative Ophthalmology & Visual Science June 2020, Vol.61, 4103. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Rachel E Linderman, Toco Yuen Ping Chui, Christopher S. Langlo, Erin Curran, Davis Zhou, Maria Virginia Castanos Toral, Judy E Kim, David V Weinberg, Richard B Rosen, Joseph Carroll; Assessing the Effect of Image Scaling on OCTA Vessel Density Deviation Mapping. Invest. Ophthalmol. Vis. Sci. 2020;61(7):4103.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Differences in axial length have been shown to alter foveal avascular zone area measures on OCTA images.1,2 We assessed the effect of differences in axial length on OCTA-based deviation mapping of vessel density.

Methods : Subjects with no known ocular or systemic pathology ("control", n = 340), macular telangectasia ("MacTel", n = 18), diabetes without retinopathy (n = 14), nonproliferative diabetic retinopathy (n = 19), and proliferative diabetic retinopathy (n = 15) underwent OCTA imaging and axial length measurement. A single nominal 3x3mm vasculature slab (inner limiting membrane to 9 µm below the outer plexiform layer) and a pixel-by-pixel density map for each subject were used. Two normative databases were constructed using density maps from control subjects, one using the device's model eye length (23.95mm) and the other using subjects’ axial lengths. For each patient with pathology, their density maps were analyzed using each of the normative databases (calculating the percentage of their density maps that were more than two standard deviations from the mean of the database).

Results : Mean (± SD) axial length was 24.23 ± 1.24 mm for control subjects, 22.99 ± 0.94 mm for patients with MacTel, and 23.55 ± 0.92 mm for all patients with diabetes. The use of scaled reference data lead to a greater absolute mean total deviation compared to unscaled reference data (0.24 ± 1.00%, Wilcoxon signed-rank test, p = 0.026). Relative differences between the use of scaled versus unscaled reference data were much greater (Figure); patients with MacTel had a relative difference of 4.1 ± 10.6% (range: -13.41 to 21.39%), while those with diabetes had a relative difference of 0.12 ± 6.98% (range: -29.17 to 17.95%).

Conclusions : Unscaled OCTA image databases result in significant underestimation of total vessel density deviation. In subjects with low (but measureable) overall deviation, differences reached 30% between the scaled and unscaled deviation maps. Correct scaling has greater impact in detecting early vessel damage or small changes in vessel density, though larger overall deviations can be detected using either scaled or unscaled data.

1PMID: 28616362
2PMID: 28622398

This is a 2020 ARVO Annual Meeting abstract.

 

Relative percent difference of the total deviation area versus the average deviation area. Bias (solid line) was 1.20% with 95% CI of 0.99-1.41% (shaded area). Data plotted separately for subjects with MacTel (crosses) and those with diabetes (open squares).

Relative percent difference of the total deviation area versus the average deviation area. Bias (solid line) was 1.20% with 95% CI of 0.99-1.41% (shaded area). Data plotted separately for subjects with MacTel (crosses) and those with diabetes (open squares).

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×